{"id":"https://openalex.org/W2004520740","doi":"https://doi.org/10.1212/wnl.43.5.876","title":"Treatment of inclusion\u2010body myositis with high\u2010dose intravenous immunoglobulin","display_name":"Treatment of inclusion\u2010body myositis with high\u2010dose intravenous immunoglobulin","alternate_titles":[],"publication_year":1993,"publication_date":"1993-05-01","ids":{"openalex":"https://openalex.org/W2004520740","doi":"https://doi.org/10.1212/wnl.43.5.876","mag":"2004520740","pmid":"https://pubmed.ncbi.nlm.nih.gov/8492940"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.43.5.876","doi":"https://doi.org/10.1212/wnl.43.5.876","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.43.5.876","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2004520740"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082044488","display_name":"Shawke A Soueidan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shawke A. Soueidan","raw_affiliation_strings":["Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD","Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 28092"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"raw_affiliation_string":"Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 28092","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090062651","display_name":"Marinos C. Dalakas","orcid":"https://orcid.org/0000-0001-7070-1134","observed_orcids":["https://orcid.org/0000-0001-7070-1134"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marinos C. Dalakas","raw_affiliation_strings":["Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuromuscular Diseases Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210110767"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.7826,"has_fulltext":false,"cited_by_count":129,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97804113,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"43","issue":"5","first_page":"876","last_page":"876"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11724","display_name":"Inflammatory Myopathies and Dermatomyositis","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inclusion-body-myositis","display_name":"inclusion body myositis","score":1.0},{"id":"https://openalex.org/keywords/intravenous-immunoglobulin","display_name":"intravenous immunoglobulin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/high-dose-ivig","display_name":"high-dose IVIG","score":0.9160000085830688},{"id":"https://openalex.org/keywords/inflammatory-myopathies","display_name":"myositis","score":0.7889999747276306},{"id":"https://openalex.org/keywords/muscle-weakness","display_name":"muscle weakness","score":0.8399999737739563},{"id":"https://openalex.org/keywords/muscle-strength","display_name":"muscle strength","score":0.6470000147819519},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C2777327098","wikidata":"https://www.wikidata.org/wiki/Q1848471","display_name":"Inclusion body myositis","level":3,"score":0.9150735139846802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8358393907546997},{"id":"https://openalex.org/C2780181341","wikidata":"https://www.wikidata.org/wiki/Q4117658","display_name":"Inflammatory myopathy","level":3,"score":0.6930235028266907},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.65574711561203},{"id":"https://openalex.org/C2780247198","wikidata":"https://www.wikidata.org/wiki/Q633403","display_name":"Weakness","level":2,"score":0.5754854679107666},{"id":"https://openalex.org/C2909916134","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulin Therapy","level":3,"score":0.5316116809844971},{"id":"https://openalex.org/C2909763950","wikidata":"https://www.wikidata.org/wiki/Q338912","display_name":"Intravenous Immunoglobulins","level":3,"score":0.5282348990440369},{"id":"https://openalex.org/C2777300911","wikidata":"https://www.wikidata.org/wiki/Q692536","display_name":"Myopathy","level":2,"score":0.5022990703582764},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46378883719444275},{"id":"https://openalex.org/C2776418732","wikidata":"https://www.wikidata.org/wiki/Q270421","display_name":"Muscle weakness","level":2,"score":0.4241834580898285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34923166036605835},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2526942491531372},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13203784823417664}],"mesh":[{"descriptor_ui":"D003402","descriptor_name":"Creatine Kinase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007116","descriptor_name":"Immunization, Passive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007136","descriptor_name":"Immunoglobulins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009220","descriptor_name":"Myositis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009220","descriptor_name":"Myositis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D009220","descriptor_name":"Myositis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.43.5.876","doi":"https://doi.org/10.1212/wnl.43.5.876","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.43.5.876","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:8492940","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8492940","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2086575353","https://openalex.org/W1970850123","https://openalex.org/W438273970","https://openalex.org/W1985693809","https://openalex.org/W2037223188","https://openalex.org/W151336953","https://openalex.org/W7214706489","https://openalex.org/W1977116220","https://openalex.org/W2081944907","https://openalex.org/W1996789173"],"abstract_inverted_index":{"We":[0],"report":[1],"the":[2,25,28,41,55,61,76,81],"treatment":[3,57],"of":[4,27,40,63,75,79],"four":[5,42],"patients":[6,67],"with":[7,68],"inclusion-body":[8],"myositis":[9],"(IBM)":[10],"and":[11,30],"severe":[12],"slowly":[13],"progressive":[14],"weakness":[15],"using":[16],"high-dose":[17],"intravenous":[18],"immunoglobulin":[19,53],"(IVIg).":[20],"After":[21],"two":[22],"monthly":[23],"infusions,":[24],"strength":[26,62],"proximal":[29],"less":[31],"atrophic":[32],"muscle":[33],"groups":[34],"improved":[35],"or":[36],"normalized":[37],"in":[38,66],"three":[39],"patients.":[43],"The":[44],"improvement":[45],"lasted":[46],"from":[47,86],"2":[48],"to":[49,59],"4":[50],"months.":[51],"Intravenous":[52],"is":[54],"first":[56],"modality":[58],"improve":[60],"some":[64],"muscles":[65],"this":[69,87],"disabling":[70],"inflammatory":[71],"myopathy.":[72],"In":[73],"view":[74],"high":[77],"cost":[78],"IVIg,":[80],"unexpected":[82],"but":[83],"encouraging":[84],"results":[85],"pilot":[88],"study":[89],"warrant":[90],"a":[91],"controlled":[92],"trial.":[93]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2004520740","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
